格隆汇12月20日｜丹麦制药公司诺和诺德(NVO.US)盘前暴跌19.17%报83.61美元；礼来盘前大涨7%。消息面上，诺和诺德此前公布了新减肥药CagriSema的实验数据：Cagrisema表现出卓越的减肥效果，服用Cagrisema的患者在试验中体重减轻了22.7%，不及此前预期。(格隆汇)

海量资讯、精准解读，尽在新浪财经APP

责任编辑：郭明煜

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.